STOCK TITAN

BlackRock (SIBN) files Schedule 13G/A reporting 6.9% ownership of SI-BONE

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BlackRock, Inc. amended a Schedule 13G to report beneficial ownership of 3,057,039 shares of SI-BONE, Inc. common stock, representing 6.9% of the class. The filing shows sole voting power for 2,997,105 shares and sole dispositive power for 3,057,039 shares. The amendment is signed by Spencer Fleming, Managing Director on 04/24/2026.

Positive

  • None.

Negative

  • None.

Insights

BlackRock discloses a 6.9% stake in SI-BONE; voting and dispositive powers are concentrated.

BlackRock reports beneficial ownership of 3,057,039 shares representing 6.9% of SI-BONE common stock, with sole voting power over 2,997,105 shares. The filing attributes holdings to Reporting Business Units of BlackRock, Inc.

Ownership above 5% must be reported and can affect engagement or voting outcomes; the filing notes various third-party rights to dividends but does not identify any single >5% holder. Future filings will show any material changes to this position.

Beneficial ownership 3,057,039 shares Amount beneficially owned reported on Schedule 13G/A
Percent of class 6.9% Percent of SI-BONE common stock reported in Item 4(b)
Sole voting power 2,997,105 shares Number with sole power to vote reported in Item 4(c)(i)
Sole dispositive power 3,057,039 shares Number with sole power to dispose reported in Item 4(c)(iii)
CUSIP 825704109 CUSIP for SI-BONE common stock listed on cover information
Signature date 04/24/2026 Filing signed by Spencer Fleming, Managing Director
Schedule 13G/A regulatory
"Amendment No. 6 to Schedule 13G/A reporting beneficial ownership"
A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.
beneficially owned regulatory
"Amount beneficially owned: 3057039 (Item 4)"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"Sole power to dispose or to direct the disposition of: 3057039"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Reporting Business Units other
"securities beneficially owned by certain business units (collectively, the "Reporting Business Units")"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does BlackRock hold in SI-BONE (SIBN)?

BlackRock reports beneficial ownership of 3,057,039 shares, equal to 6.9% of SI-BONE common stock. This figure appears on Amendment No. 6 to the Schedule 13G/A filed in the provided excerpt.

How much voting power does BlackRock have in SI-BONE (SIBN)?

The filing shows BlackRock has sole voting power over 2,997,105 shares. It reports no shared voting power for this position in the excerpt provided.

Who signed the Schedule 13G/A amendment for BlackRock on SI-BONE?

Spencer Fleming, Managing Director, signed the amendment on 04/24/2026. The signature and title are included on the form's signature block in the excerpt.

Does the filing identify other persons with dividend or sale rights over these SI-BONE shares?

The filing states that various persons have rights to dividends or proceeds, but it does not identify any single person with more than 5% interest. A list of shareholders of registered investment companies is not required.

What address is listed for BlackRock in this Schedule 13G/A?

BlackRock's principal business office is listed as 50 Hudson Yards, New York, NY 10001 in Item 2(b) of the filing excerpt.





825704109

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:04/24/2026
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7